Results 11 to 20 of about 86,753 (203)
A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin [PDF]
Clinical Case Reports, 2020 Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement ...
Federico Meconi +9 more
doaj +3 more sources
Ca-A Cancer Journal for Clinicians, 1993 Radiotherapy is curative for localized Hodgkin's disease,1,2 and there is now general agreement that advanced Hodgkin's disease can be cured by chemotherapy. This opinion is bolstered by the 20-year survival experience of the original group of patients treated with combination chemotherapy at the National Cancer Institute (Figure 1) and by experience ...
Bruce A Peterson
exaly +7 more sources
Hodgkin Disease—An Ever-Evolving Therapy [PDF]
Rambam Maimonides Medical Journal, 2014 Therapy of Hodgkin lymphoma (HL) is a rapidly changing field due to plenty of currently emerging data. Treatment approaches are currently based on tailoring of therapy in order to achieve a maximal response with minimal toxicity.
Eldad J. Dann
doaj +2 more sources
Different faces of cutaneous Hodgkin′s disease
Indian Journal of Dermatopathology and Diagnostic Dermatology, 2014 Hodgkin′s disease with skin involvement is a rare entity with a reported incidence of 0.5-3.5%. Various routes of skin involvement may include retrograde lymphatic spread, direct extension from underlying nodes, or hematogenous spread.
Shikha Goyal +5 more
doaj +2 more sources
Hodgkin Lymphoma and Castleman Disease: When One Blood Disease Can Hide Another [PDF]
Case Reports in Hematology, 2017 We describe a rare case of Castleman disease associated de novo with Hodgkin lymphoma. The incidence of Castleman disease is rare; only a few studies have described it in de novo association with Hodgkin lymphoma. The patient described here complained of
L. Filliatre-Clement +4 more
doaj +2 more sources
Immune Thrombocytopenic Purpura Evolving into Hodgkin’s Disease in a Young Boy [PDF]
Bengal Physician Journal, 2022 Immune thrombocytopenic purpura (ITP) is a common bleeding disorder, and it may be primary (no potential etiologies found) or secondary (underlying associated conditions).
Karimulla Mondal +4 more
doaj +1 more source
Classical Hodgkin lymphoma following follicular lymphoma: a case report [PDF]
Journal of Yeungnam Medical Science, 2023 The simultaneous, composite, or sequential occurrence of follicular lymphoma (FL) and classical Hodgkin lymphoma (HL), both of which originate from germinal center B-cell, is rare.
Bomi Kim
doaj +1 more source
Impact of Cox2, CD163, and Microvessel Density Expression on the Prediction of Relapse and Patients’ Outcome in Classical Hodgkin Lymphoma [PDF]
Middle East Journal of Cancer, 2022 Background: Tumor microenvironment, specifically tumor-associated macrophages, plays an important role in tumor initiation and progression. CD163 has been recognized as a valuable specific macrophage marker.
Rania Makboul +6 more
doaj +1 more source
Cell Reports, 2023 Summary: Variants at the GBA locus, encoding glucocerebrosidase, are the strongest common genetic risk factor for Parkinson’s disease (PD). To understand GBA-related disease mechanisms, we use a multi-part-enrichment proteomics and post-translational ...
Helle Bogetofte +22 more
doaj +1 more source
Hodgkin's Disease--A Curable Disease [PDF]
Ca-A Cancer Journal for Clinicians, 1964 Roald N Grant
exaly +3 more sources